Fundamental Analysis
59 / 100BRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +92.8% | +52.1% | 3 / 3 | +4.3% | +2.23 pp | +2.88 pp | +11.5% | 2.45 | 8.15 | 1.271 | +4,3% | 66,2 | +133,3% | 8.15 | 12.63 | −35,5% |
| Pts | 12 | 12 | 12 | 0 | 8 | 12 | 0 | -4 | 12 | |||||||
Valuation annotation:Price: 11.700 (close price on 2026-10-19)EPS (TTM): 1.435
Financial charts
1.Revenue & growth
VND bn1.271Q2/26
1.Revenue & growth
VND bn1.271Q2/26
2.Profit & growth
VND bn66,2Q2/26
3.Profit mix (Penman)
VND bn179Q2/26
4.Margins & cost structure
%9.3%Q2/26
5.Returns & cash cycle
% · days9.0%Q2/26
6.Earnings quality & cash
VND bn191Q2/26
7.Asset structure
VND bn5.963Q2/26
8.Funding & debt health
VND bn · times5.963Q2/26
9.Revenue backlog
VND bn30,6Q2/26
10.Valuation
times · %8,8×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %568Q2/26
Adjusted EPS growth, latest quarter
112%
Average adjusted EPS growth, 3 quarters
58.6%
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
10.0%
Source: vnstockData through Q2/26